DJ Oncternal Therapeutics Initiated at Outperform by Oppenheimer
Ratings actions from Benzinga: https://www.benzinga.com/stock/ONCT/ratings
(END) Dow Jones Newswires
April 07, 2021 06:29 ET (10:29 GMT)
DJ Oncternal Therapeutics Price Target Announced at $14.00/Share by Oppenheimer
Ratings actions from Benzinga: https://www.benzinga.com/stock/ONCT/ratings
(END) Dow Jones Newswires
April 07, 2021 06:29 ET (10:29 GMT)